{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:53:04Z","timestamp":1761562384590,"version":"3.41.2"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T00:00:00Z","timestamp":1528675200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1016494"],"award-info":[{"award-number":["1016494"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007744","name":"Association pour le Developpement et l\u2019Organisation de la Recherche en Pneumologie et sur le Sommeil","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-EMMA-0030-01 EEG-PVI"],"award-info":[{"award-number":["ANR-11-EMMA-0030-01 EEG-PVI"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00621","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T07:40:12Z","timestamp":1528702812000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of Biologic Treatment of Crohn\u2019s Disease on the Rate of Surgeries and Other Healthcare Resources: An Analysis of a Nationwide Database From Poland"],"prefix":"10.3389","volume":"9","author":[{"given":"Przemys\u0142aw","family":"Holko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"Kawalec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Pilc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/ecco-jcc\/jjv190","article-title":"Impact of new treatments on hospitalisation, surgery, infection, and mortality in IBD: a focus paper by the epidemiology committee of ECCO.","volume":"10","author":"Annese","year":"2016","journal-title":"J. Crohns Colitis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","article-title":"Crohn\u2019s disease.","volume":"380","author":"Baumgart","year":"2012","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.cgh.2007.01.015","article-title":"Trends in hospitalization rates for inflammatory bowel disease in the United States.","volume":"5","author":"Bewtra","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.crohns.2013.01.010","article-title":"ECCO -EpiCom. The burden of inflammatory bowel disease in Europe.","volume":"7","author":"Burisch","year":"2013","journal-title":"J. Crohns Colitis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1097\/MIB.0b013e31829936c2","article-title":"Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease: a systematic review and meta-analysis.","volume":"19","author":"Costa","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/bmj.39547.603218.AE","article-title":"Medical management of Crohn\u2019s disease.","volume":"336","author":"Cummings","year":"2008","journal-title":"BMJ"},{"key":"B7","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1053\/j.gastro.2013.07.041","article-title":"Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta analysis of population-based studies.","volume":"145","author":"Frolkis","year":"2013","journal-title":"Gastroenterology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/apt.13276","article-title":"Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy.","volume":"42","author":"Gisbert","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/MEG.0000000000001047","article-title":"Prevalence and drug treatment practices of inflammatory bowel diseases in Poland in the years 2012\u20132014: an analysis of nationwide databases.","volume":"30","author":"Holko","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145087","article-title":"A systematic review of the cost-effectiveness of biologics for the treatment of inflammatory bowel diseases.","volume":"10","author":"Huoponen","year":"2015","journal-title":"PLoS ONE"},{"key":"B11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/ajg.2016.524","article-title":"Improvements in the long-term outcome of crohn\u2019s disease over the past two decades and the relation to changes in medical management: results from the population-based IBDSL cohort.","volume":"112","author":"Jeuring","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/ibd.21118","article-title":"Small bowel resection rates in Crohn disease and the indication for surgery over time: experience from a large tertiary care center.","volume":"16","author":"Lazarev","year":"2010","journal-title":"Inflamm. Bowel. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/apt.13847","article-title":"Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn\u2019s disease and ulcerative colitis.","volume":"45","author":"Mao","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/ibd.20250","article-title":"Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004.","volume":"13","author":"Nguyen","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1053\/j.gastro.2006.05.052","article-title":"Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.","volume":"131","author":"Odes","year":"2006","journal-title":"Gastroenterology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1097\/MIB.0000000000000061","article-title":"Utilization trends of anti-TNF agents and health outcomes in adults and children with inflammatory bowel diseases: a single-center experience.","volume":"20","author":"Park","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"B18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/MOG.0000000000000078","article-title":"Complications and surgery in the inflammatory bowel diseases biologic era.","volume":"30","author":"Sokol","year":"2014","journal-title":"Curr. Opin. Gastroenterol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/ecco-jcc\/jjv099","article-title":"Treatment steps, surgery, and hospitalization rates during the first year of follow-up in patients with inflammatory bowel diseases from the 2011 ECCO-epicom inception cohort.","volume":"9","author":"Vegh","year":"2015","journal-title":"J. Crohns Colitis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/ajg.2014.45","article-title":"Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy.","volume":"109","author":"Vester-Andersen","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von Elm","year":"2008","journal-title":"J. Clin. Epidemiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00621\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T07:40:20Z","timestamp":1528702820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00621\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,11]]},"references-count":21,"alternative-id":["10.3389\/fphar.2018.00621"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00621","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2018,6,11]]},"article-number":"621"}}